
Bioventus Inc.
USD8.55
+0.44 (+5.43%)
CEO
Robert E. Claypoole
IPO Date
2021-02-11
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$8.13
Prev. Close
$8.11
Day Low
$8.10
Day High
$8.62
52W Low
$5.81
52W High
$11.25
Market Cap
$0.58B
Volume
1.35M
| 17 Mar 2025 |
| Canaccord Genuity |
| Buy |
| Buy |
| maintain |
| 17 Dec 2024 | JP Morgan | Underweight | Neutral | upgrade |
| 6 Nov 2024 | Canaccord Genuity | Buy | Buy | maintain |
| 27 Sept 2024 | Craig-Hallum | Buy | Buy | maintain |
| 13 Aug 2024 | Canaccord Genuity | Buy | Buy | maintain |
| 7 Aug 2024 | Craig-Hallum | Buy | Buy | maintain |
| 8 May 2024 | Canaccord Genuity | Buy | Buy | maintain |